𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hemizygous or homozygous deletion of the chromosomal region containing the p16INK4a gene is associated with amplification of the EGF receptor gene in glioblastomas

✍ Scribed by Monika E. Hegi; Axel zur Hausen; Daniela Rüedi; Gerhard Malin; Paul Kleihues

Publisher
John Wiley and Sons
Year
1997
Tongue
French
Weight
144 KB
Volume
73
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ABL oncogene amplification with p16INK4a
ABL oncogene amplification with p16INK4a gene deletion in precursor T-cell acute lymphoblastic leukemia/lymphoma: Report of the first case
✍ Hee-Jin Kim; Hee-Yeon Woo; Hong-Hoe Koo; Eun-Young Tak; Sun-Hee Kim 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract Gene amplification is a relatively rare event in hematologic malignancies. The __ABL__ gene on chromosome band 9q34 is a proto‐oncogene and is the well‐known translocation partner of the __BCR__ gene on 22q11 giving rise to t(9;22)(q34;q11), which is the hallmark of chronic myeloid leuk

Establishment of a novel human B-cell li
Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes
✍ M. Nagai; M. Fujita; M. Ohmori; S. Matsubara; M. Taniwaki; S. Horiike; T. Tasaka 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

The novel human pre-B cell line OZ was established from a patient with an aggressive form of non-Hodgkin's lymphoma. Karyotypic analysis of both the primary tumour and OZ cells revealed several marker chromosomes, including the t(14;18)(q32;q21) translocation, which involves the Bcl-2 gene, and alte

Amplification of the androgen receptor g
Amplification of the androgen receptor gene is associated with P53 mutation in hormone-refractory recurrent prostate cancer
✍ Koivisto, Pasi A.; Rantala, Immo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

p53 protein expression of 30 hormone-refractory locally recurrent prostate cancers was compared with their matched untreated primary tumour specimens. In addition, androgen receptor (AR) gene amplification and p53 protein immunostaining were compared. p53 positivity increased during hormonal therapy